Mulmit

Moleculin Biotech, Inc.Moleculin Biotech, Inc.

MBRX Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-310-25,103,00033,560,000
2024-12-310-26,641,00026,048,000
2023-12-310-29,631,00029,769,000
2022-12-310-30,640,000-29,025,000
2021-12-310-22,968,000-15,894,000

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-03Foster Jonathan P.Chief Financial Officer293,333
2026-08-03Foster Jonathan P.Chief Financial Officer879,999
2026-08-03KLEMP WALTER VCEO and President533,333
2026-08-03KLEMP WALTER VCEO and President1,599,999
2026-08-03PICKER DONALD HChief Science Officer173,333
2026-08-03PICKER DONALD HChief Science Officer519,999
2026-06-22PICKER DONALD HChief Science Officer71
2026-06-22PICKER DONALD HChief Science Officer21
2026-06-22PICKER DONALD HChief Science Officer71
2026-06-22KLEMP WALTER VCEO and President360
2026-06-22KLEMP WALTER VCEO and President88
2026-06-22KLEMP WALTER VCEO and President360

8-K events

FiledItems
2026-09-18Delisting or listing-standard notice
2026-09-14Regulation FD disclosure · Financial statements and exhibits
2026-08-31Regulation FD disclosure · Financial statements and exhibits
2026-08-14Results of operations · Financial statements and exhibits
2026-08-03Entry into a material agreement · Financial statements and exhibits
2026-07-31Regulation FD disclosure · Financial statements and exhibits
2026-06-30Regulation FD disclosure · Financial statements and exhibits
2026-06-30Regulation FD disclosure · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…